Breaking News

Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract

The team will provide manufacturing and nonclinical support for translational development of therapeutic biotechnology products in the NIHs drug discovery and development program that addresses neurological conditions.

Battelle, Amplify, and Andelyn Biosciences, have won a seat on an eight-year, $149 million indefinite delivery, indefinite quantity (IDIQ) contract vehicle for the National Institute of Neurological Disorders and Stroke. As one of the prime contractors on the multi-award IDIQ, the team will provide manufacturing and nonclinical support for translational development of therapeutic biotechnology products in the National Institutes of Health’s drug discovery and development program that addresse...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters